HETERO LABS LTD III FDA Approval ANDA 090636

ANDA 090636

HETERO LABS LTD III

FDA Drug Application

Application #090636

Documents

Letter2010-04-05

Application Sponsors

ANDA 090636HETERO LABS LTD III

Marketing Status

Prescription001

Application Products

001TABLET;ORAL300MG0TENOFOVIR DISOPROXIL FUMARATETENOFOVIR DISOPROXIL FUMARATE

FDA Submissions

ORIG1AP2018-01-26
UNKNOWN; ORIG2AP2018-01-26STANDARD
LABELING; LabelingSUPPL9AP2020-01-23STANDARD

Submissions Property Types

ORIG1Null1
SUPPL9Null15

TE Codes

001PrescriptionAB

CDER Filings

HETERO LABS LTD III
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 90636
            [companyName] => HETERO LABS LTD III
            [docInserts] => ["",""]
            [products] => [{"drugName":"TENOFOVIR DISOPROXIL FUMARATE","activeIngredients":"TENOFOVIR DISOPROXIL FUMARATE","strength":"300MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"TENOFOVIR DISOPROXIL FUMARATE","submission":"TENOFOVIR DISOPROXIL FUMARATE","actionType":"300MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.